cliffordfosterr
Member
Eriacta 100 mg, as a Ranbaxy‑manufactured generic sildenafil, has been evaluated indirectly through both Indian access studies and broader clinical trial programmes on sildenafil citrate. Efficacy: Phase III–IV trials and meta‑analyses confirm significant improvements in erectile function versus placebo across diverse populations. Safety: Known side effects at the 100 mg dose include headache, flushing, dyspepsia, and transient visual changes; serious adverse events are rare and similar to placebo. Long‑term use: Data from extension studies show maintained effectiveness over months with high patient satisfaction.